Plain-English translation of NCT07232537 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is collecting information about how finerenone works when prescribed by doctors to people with chronic kidney disease (gradual loss of kidney function) related to type 2 diabetes (a blood sugar disorder). The medication is already approved and available for patients — this research simply gathers data on how it's being used and how patients respond to it in real medical practices in South Korea.
When kidney disease develops from diabetes, it can get progressively worse and affect the heart as well. This medication is designed to protect the kidneys by reducing harmful inflammation, but researchers want to learn more about how safely and effectively this treatment works in actual Korean patients receiving everyday medical care.
You likely qualify if…
You likely don't qualify if…
Your participation involves allowing researchers to collect information from your medical records — such as your kidney function tests, blood pressure, heart health, medications, and how long you take this treatment. There are no extra doctor visits or procedures required beyond your normal medical care. The study team will simply observe and document your real-world treatment experience as your doctor manages your kidney disease and diabetes.
AI-generated summary from trial data · Jun 21, 2026 · Not medical advice
South Korea